Behind the Money cover image

Ozempic’s unconventional origins

Behind the Money

CHAPTER

The Origins and Unique Ownership of Novo Nordisk

This chapter discusses the origins of Novo Nordisk, a pharmaceutical company, and explores its unique ownership structure, including the role of the Novo Nordisk Foundation. It also highlights the advantages of having a controlling shareholder like a foundation and the company's ability to take a long-term view in their planning.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner